Christelle Butel
Biographic Data
| ID | 6217530 |
|---|---|
| NAME | Christelle Butel |
| GIVEN NAMES | Christelle |
| FAMILY NAME | Butel |
| SIGNATURE | BUTEL C |
| AFFILIATIONS | Inserm |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023
Monitoring pre-treatment drug resistance is a priority to assess the emergence of HIV resistance to antiretrovirals, especially in countries where the transition from dolutegravir-based regimens is already effective on a large scale. The aim of this study was to estimate the prevalence of resistance mutations to different classes of antiretrovirals (ARVs) in HIV-1-naïve persons in Togo in 2023. A cross-sectional study was conducted in 30 HIV care…
No prominent works on this page.
Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023
Monitoring pre-treatment drug resistance is a priority to assess the emergence of HIV resistance to antiretrovirals, especially in countries where the transition from dolutegravir-based regimens is already effective on a large scale. The aim of this study was to estimate the prevalence of resistance mutations to different classes of antiretrovirals (ARVs) in HIV-1-naïve persons in Togo in 2023. A cross-sectional study was conducted in 30 HIV care…
Biological Research and Disease Studies (1 work) · Dolutegravir (1 work) · Drug resistance (1 work) · Elvitegravir (1 work) · HIV drug resistance (1 work) · HIV Research and Treatment (1 work) · HIV/AIDS drug development and treatment (1 work) · Integrase (1 work) · Integrase inhibitor (1 work) · Interquartile range (1 work)